DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Gujarat Ambuja Exports GAEL Q2 FY27 Results Member Communication

Kalkine India 20 hrs ago·24 Oct 2026, 11:00 am

Gujarat Ambuja Exports (GAEL) has released its Q2 FY27 member communication, providing an update on its financial performance and strategic direction. The company is a key player in the specialty chemicals sector, focusing on exports and manufacturing.

This update is significant for investors as it offers transparency into the company's operational health and future outlook. Understanding GAEL's performance is crucial for assessing its growth potential and competitive standing in the specialty chemicals market.

Investors should watch for details on the company's export volumes, raw material costs, and any strategic initiatives mentioned in the communication. These factors will be key in determining the company's trajectory in the coming quarters.